journal article·2022-04-13

A High Throughput Approach for Designing Polymers That Mimic the TRAIL Protein

Zihao Li, Zifei Han, Martina H. Stenzel, Robert Chapman

Nano Letters· Volume 22· Issue 7
Publisher page

Abstract

We have leveraged a high throughput approach to design a fully synthetic polymer mimic of the chemotherapeutic protein “TRAIL”. Our design enables the synthesis of libraries of star-shaped polymers presenting exactly one receptor binding peptide at the end of each arm with no purification steps. Clear structure–activity relationships in screening for receptor binding and the apoptotic activity on colon cancer lines (COLO205) led us to identify trivalent structures, ∼1.5 nm in hydrodynamic radius as the best mimics. These showed IC50 values ∼2 μM and resulted in the elevated levels of caspase-8 expected from this mechanism of cell death. Our results demonstrate the potential for HTP screening methods to be used in the design of polymers that can mimic a whole range of complex therapeutic proteins.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Protein Structure and Dynamics · RNA and protein synthesis mechanisms · Mass Spectrometry Techniques and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Centre for Advanced Macromolecular Design, School of Chemistry, Univeristy of New South Wales Sydney, Kensington, New South Wales 2052, Australia

School of Environmental and Life Sciences, University of Newcastle, Callaghan, New South Wales 2308, Australia

Funding

Australian Research Council

References (56)

Show source-provided references
1. 10.1002/anie.20180900610.1002/anie.201809006 ↗
2. 10.1002/bit.2205610.1002/bit.22056 ↗
3. 10.1016/j.biomaterials.2018.10.00710.1016/j.biomaterials.2018.10.007 ↗
4. 10.1038/nnano.2013.20510.1038/nnano.2013.205 ↗
5. 10.1021/acschembio.5b0023910.1021/acschembio.5b00239 ↗
6. 10.1039/C4BM00442F10.1039/C4BM00442F ↗
7. 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-310.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3 ↗
8. Krishnamurthy V. M. · 2006 · 1110.1002/3527608761.ch2 ↗
9. 10.1021/acs.bioconjchem.8b0080410.1021/acs.bioconjchem.8b00804 ↗
10. 10.1002/anie.20100420110.1002/anie.201004201 ↗
11. Curk T. · 2017 · 7510.1002/9781119143505.ch3 ↗
12. 10.1016/j.cbpa.2010.02.01810.1016/j.cbpa.2010.02.018 ↗
13. 10.1038/nrd336810.1038/nrd3368 ↗
14. 10.1039/C7CS00587C10.1039/C7CS00587C ↗
15. 10.1021/acs.macromol.8b0186410.1021/acs.macromol.8b01864 ↗
16. 10.1021/acs.macromol.9b0029010.1021/acs.macromol.9b00290 ↗
17. 10.1021/acs.macromol.9b0220710.1021/acs.macromol.9b02207 ↗
18. 10.1021/acsmacrolett.9b0009110.1021/acsmacrolett.9b00091 ↗
19. 10.1021/ja501745g10.1021/ja501745g ↗
20. 10.1039/C7PY00007C10.1039/C7PY00007C ↗
21. 10.1002/anie.20180299210.1002/anie.201802992 ↗
22. 10.1002/anie.20171104410.1002/anie.201711044 ↗
23. 10.1021/acs.jchemed.9b0092210.1021/acs.jchemed.9b00922 ↗
24. 10.1021/ja905409610.1021/ja9054096 ↗
25. 10.1021/ja105066t10.1021/ja105066t ↗
26. 10.1016/j.polymer.2017.02.07110.1016/j.polymer.2017.02.071 ↗
27. 10.1016/j.polymer.2017.12.07110.1016/j.polymer.2017.12.071 ↗
28. 10.1021/jacs.9b0989910.1021/jacs.9b09899 ↗
29. 10.1126/science.276.5309.11110.1126/science.276.5309.111 ↗
30. 10.1126/science.281.5381.130510.1126/science.281.5381.1305 ↗
31. 10.1038/nrd393010.1038/nrd3930 ↗
32. 10.1073/pnas.051018710310.1073/pnas.0510187103 ↗
33. 10.1016/j.canlet.2012.04.00710.1016/j.canlet.2012.04.007 ↗
34. Kelley S. K. · J. Pharmacol. Exp. Ther. · 2001 · 299 · 31
35. 10.1200/JCO.2007.15.719810.1200/JCO.2007.15.7198 ↗
36. 10.1038/cdd.2014.8110.1038/cdd.2014.81 ↗
37. 10.1038/cdd.2015.17410.1038/cdd.2015.174 ↗
38. 10.1158/0008-5472.CAN-09-288910.1158/0008-5472.CAN-09-2889 ↗
39. 10.1002/chem.20120241510.1002/chem.201202415 ↗
40. 10.1002/cbic.20190025110.1002/cbic.201900251 ↗
41. 10.1038/nmat343010.1038/nmat3430 ↗
42. 10.1021/acsnano.0c1010410.1021/acsnano.0c10104 ↗
43. 10.1002/anie.20151189410.1002/anie.201511894 ↗
44. 10.1016/S1074-7613(00)80100-410.1016/S1074-7613(00)80100-4 ↗
45. 10.1016/j.jmb.2006.06.04210.1016/j.jmb.2006.06.042 ↗
46. 10.1006/abio.2000.472610.1006/abio.2000.4726 ↗
47. 10.1038/sj.onc.120652010.1038/sj.onc.1206520 ↗
48. 10.1038/3500866710.1038/35008667 ↗
49. 10.1038/sj.cdd.440188610.1038/sj.cdd.4401886 ↗
50. 10.1158/1535-7163.MCT-13-032310.1158/1535-7163.MCT-13-0323 ↗
51. 10.1074/jbc.M30489620010.1074/jbc.M304896200 ↗
52. Nagane M. · Cancer Res. · 2000 · 60 · 847
53. Singh T. R. · Cancer Res. · 2003 · 63 · 5390
54. 10.1038/sj.onc.120783010.1038/sj.onc.1207830 ↗
55. 10.1093/carcin/bgh18810.1093/carcin/bgh188 ↗
56. 10.1016/S1097-2765(03)00059-510.1016/S1097-2765(03)00059-5 ↗